Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs. Interferon-alpha Alone in Patients With Advanced Renal Cell Carcinoma

NCT00053820 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00053820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs. Interferon-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Lead sponsor
Medical Research Council
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
December 31, 2006
Enrollment
670 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer